Skip to main content



coactiv+™ Antimicrobial Wound Gel is a premium hydrogel that provides scientifically-proven efficacy for wound healing in an easy-to-use thermo-reversible gel, all within Medicare and private payor allowables.

Why Use Any Other Hydrogel?


A unique combination of Kane Biotech’s patented coactiv+™ technology with PHMB provides a moist environment best suited for wound healing with effective antimicrobial activity in the gel.

Ease Of Use

A non-ionic pluronic surfactant with thermo-gelling properties allows the wound gel to be easily applied, stay on the wound, and easy to rinse off, making it ideal for sensitive wounds.


The only premium hydrogel that checks off ALL the boxes, at a price point that fully fits within Medicare and private payor allowables, making it accessible to all patients affordably.

coactiv+™ Antimicrobial Wound Gel is indicated for the use on:

  • Partial and full thickness wounds
  • Leg ulcers
  • Large surface area wounds
  • Pressure ulcers
  • Surgical incisions
  • 1st and 2nd degree burns
  • Diabetic foot ulcers

coactiv+™ Antimicrobial Wound Gel Main Components

  • coactiv+™
    (EDTA and Citric Acid)
  • PHMB
  • Non-ionic
    pluronic surfactant

Biofilm impaired healing - the largest unresolved problem in wound care.

Studies have reported a prevalence of biofilms in over 78% of chronic wounds. Biofilms are a glue-like substance excreted by bacteria and/or fungi to attach to surfaces. They protect and allow bacteria to survive and thrive in hostile environments. Biofilms make bacteria up to 1,000 times more resistant to antibiotics and antimicrobials and are one of the main contributors to antibiotic resistance.

coactiv+™ Antimicrobial Wound Gel is effective against:


Escherichia coli
Acinetobacter baumannii
Klebsiella pneumoniae
Pseudomonas aeruginosa


Staphylococcus aureus
Methicillin Resistant Staphylococcus aureus
Enterococcus faecalis
Streptococcus pyogenes
Cutibacterium acnes


Candida albicans

About Kane Biotech

Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (80 patents and patents pending, trade secrets and trademarks) and products developed by the Company’s own biofilm research expertise and acquired from leading research institutions. Kane®, StrixNB™, DispersinB®, Aledex™, bluestem™, bluestem®, silkstem™, goldstem™, coactiv+™, coactiv+®, DermaKB™ and DermaKB Biofilm™ are trademarks of Kane Biotech Inc. The Company is listed on the TSX Venture Exchange under the symbol “KNE” and on the OTCQB Venture Market under the symbol “KNBIF”.

Please contact us for more information

Close Menu
Phone: (204) 453-1301

290-100 Innovation Drive
Winnipeg, Manitoba, Canada, R3T 6G2